PIGW‐related glycosylphosphatidylinositol deficiency: Description of a new patient and review of the literature
暂无分享,去创建一个
[1] M. Kirschfink,et al. Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management. , 2019, Molecular immunology.
[2] D. Horn,et al. Mutations in PIGU Impair the Function of the GPI Transamidase Complex, Causing Severe Intellectual Disability, Epilepsy, and Brain Anomalies. , 2019, American journal of human genetics.
[3] J. Rosenfeld,et al. Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases. , 2019, American journal of human genetics.
[4] A. Vignoli,et al. Pathogenic Variants in STXBP1 and in Genes for GABAa Receptor Subunities Cause Atypical Rett/Rett-like Phenotypes , 2019, International journal of molecular sciences.
[5] Wei Wei,et al. Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report , 2019, BMC Pediatrics.
[6] R. Chaoui,et al. Exome sequencing of fetal anomaly syndromes: novel phenotype–genotype discoveries , 2019, European Journal of Human Genetics.
[7] Philippe M. Campeau,et al. Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders , 2018, Clinical genetics.
[8] Denise L. Perry,et al. Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy. , 2018, American journal of human genetics.
[9] D. Stevenson,et al. Use of Flow Cytometry for Diagnosis of Epilepsy Associated With Homozygous PIGW Variants. , 2018, Pediatric Neurology.
[10] T. Kinoshita,et al. Paroxysmal nocturnal haemoglobinuria , 2017, Nature Reviews Disease Primers.
[11] Keith Nykamp,et al. Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.
[12] J. Jaeken,et al. What is new in CDG? , 2017, Journal of Inherited Metabolic Disease.
[13] L. Biesecker,et al. A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model , 2017, PloS one.
[14] D. Krasnewich,et al. Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview , 2017 .
[15] T. Kinoshita,et al. A novel mutation in PIGW causes glycosylphosphatidylinositol deficiency without hyperphosphatasia , 2016, American journal of medical genetics. Part A.
[16] Philippe M. Campeau,et al. Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability , 2016, Journal of Medical Genetics.
[17] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[18] T. Kinoshita,et al. Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome , 2013, Journal of Medical Genetics.
[19] K. Manasco,et al. Adrenocorticotropic Hormone for the Treatment of West Syndrome in Children , 2013, The Annals of pharmacotherapy.
[20] M. Sana,et al. Extensive arterial tortuosity and severe aortic dilation in a newborn with an EFEMP2 mutation. , 2012, Circulation.
[21] Gert Matthijs,et al. CDG nomenclature: time for a change! , 2009, Biochimica et biophysica acta.
[22] Y. Maeda,et al. Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress. , 2008, Journal of biochemistry.
[23] Y. Maeda,et al. PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor. , 2003, Molecular biology of the cell.